search
Back to results

Interest of Indocyanine Green in Neoplastic Prostatic Tissue

Primary Purpose

Prostatic Neoplasms

Status
Withdrawn
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
indocyanine green infusion
Sponsored by
Centre Hospitalier Universitaire de Saint Etienne
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Prostatic Neoplasms focused on measuring Prostatic Neoplasms, Prostate cancer, surgical margins, indocyanine green, characterization, prostatectomy, peroperative, detection

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with prostatic cancer proved by biopsy and needing total prostatectomy with or without curettage.
  • Patient affiliated to a social security scheme
  • Patient has given its informed consent

Exclusion Criteria:

  • contra-indication to surgery
  • non confirmed adenocarcinoma diagnostic
  • antecedent of prostatic cancer treatment
  • antecedent of pelvic surgery

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    patient with Indocyanine green infusion

    Arm Description

    Infusion of Indocyanine Green 0,25 mg/Kg 24h before prostatic surgery

    Outcomes

    Primary Outcome Measures

    Sensitivity of indocyanine green
    Sensitivity (true positive) of the fluorescence due to indocyanine green to detect neoplasm tissue in prostatic biopsy compared to histological analysis

    Secondary Outcome Measures

    Specificity of indocyanine green
    Specificity (true negative) of the fluorescence due to indocyanine green to detect neoplasm tissue in prostatic biopsy compared to histological analysis

    Full Information

    First Posted
    September 25, 2014
    Last Updated
    March 9, 2016
    Sponsor
    Centre Hospitalier Universitaire de Saint Etienne
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02260349
    Brief Title
    Interest of Indocyanine Green in Neoplastic Prostatic Tissue
    Official Title
    Interest of Indocyanine Green in the Neoplastic Prostatic Tissue Characterization and the Peroperative Surgical Margins Detection During a Radical Prostatectomy.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2016
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    Scientific coordinator left the hospital
    Study Start Date
    April 2014 (undefined)
    Primary Completion Date
    February 2016 (Actual)
    Study Completion Date
    February 2016 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Centre Hospitalier Universitaire de Saint Etienne

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Prostate cancer, with more than 70,000 new cases and 8900 deaths a year in France, is a major public health problem. Until 28% of patients treated with surgery will present a positive surgical margin resulting in an incomplete clearance of the tumoral process and exposing so the patient at a local, systemic recurrence and increased morbidity. An increasing number of international publications have shown (ICG) was interesting for the detection of the sentinel lymph node, in the surgery of tumors of type hepatocarcinoma and liver metastases from colorectal diseases, but also in the surgery of the kidney, bladder or breast. ICG has affinity for tumor and tissues around the tumor related to micro-vascular histology for a localized and specific deposit (EPR effect). The detection of ICG 's deposits is now possible with to the use of a device which allow to visualize the infra-red fluorescence (NIR; Near Infra-Red) for objects larger than 0.15 mm. Thanks to this feature, the location of residual tumor tissue when performing a radical prostatectomy could be made much easier.
    Detailed Description
    The ability of ICG to detect a surgical margin positive intraoperatively has never be evaluated. We want to perform a monocentric prospective ex-vivo pilot in order to evaluate the diagnostic performance of fluorescence in the detection of surgical margins compared to pathologic analysis. This study will be conducted in 37 patients operated on for a radical prostatectomy after systemic injection of 0, 25 mg/Kg of ICG 24 h before the surgery. The fluorescence analysis will be performed in the operation room and then specimen will be sent to the laboratory for an analysis as usual. Two pieces of prostate will be prelevated according to a protocol. The histopathological procedure will be performed without knowledge of fluorescence analysis. Except the ICG injection the medical procedure won't be changed.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Prostatic Neoplasms
    Keywords
    Prostatic Neoplasms, Prostate cancer, surgical margins, indocyanine green, characterization, prostatectomy, peroperative, detection

    7. Study Design

    Primary Purpose
    Diagnostic
    Study Phase
    Phase 3
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    patient with Indocyanine green infusion
    Arm Type
    Experimental
    Arm Description
    Infusion of Indocyanine Green 0,25 mg/Kg 24h before prostatic surgery
    Intervention Type
    Drug
    Intervention Name(s)
    indocyanine green infusion
    Intervention Description
    intravenous injection (0,25mg/kg) of the indocyanine green 24h before prostatic surgery.
    Primary Outcome Measure Information:
    Title
    Sensitivity of indocyanine green
    Description
    Sensitivity (true positive) of the fluorescence due to indocyanine green to detect neoplasm tissue in prostatic biopsy compared to histological analysis
    Time Frame
    24h after indocyanine green infusion
    Secondary Outcome Measure Information:
    Title
    Specificity of indocyanine green
    Description
    Specificity (true negative) of the fluorescence due to indocyanine green to detect neoplasm tissue in prostatic biopsy compared to histological analysis
    Time Frame
    24h after indocyanine green infusion

    10. Eligibility

    Sex
    Male
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients with prostatic cancer proved by biopsy and needing total prostatectomy with or without curettage. Patient affiliated to a social security scheme Patient has given its informed consent Exclusion Criteria: contra-indication to surgery non confirmed adenocarcinoma diagnostic antecedent of prostatic cancer treatment antecedent of pelvic surgery
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Nicolas MOTTET, PhD
    Organizational Affiliation
    CHU SAINT-ETIENNE
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Interest of Indocyanine Green in Neoplastic Prostatic Tissue

    We'll reach out to this number within 24 hrs